UPCOMING SESSIONS in ET
Tue, May 26, 2026
5:00 – 6:00 AM Bangkok
Advocacy 101: Finding Your Voice & Speaking Up with Confidence Thomas Bartlett Click To Register
UPCOMING SESSIONS in ET
Tue, May 26, 2026 · 5:00 – 6:00 AM Bangkok
Advocacy 101: Finding Your Voice & Speaking Up with Confidence
Thomas Bartlett
Click To Register
View all sessions
Documenting my dad's journey with AL Amyloidosis. "When oceans rise, my soul will rest in Your embrace. For I am Yours and You are mine!"
Hematologist and Oncologist, Director, Amyloidosis Center @amyloidosis_bu. Hematologist and Oncologist @The_BMC
Supporting patients and families while promoting research, education and awareness.
Cardiologist at Mayo Clinic. Former junior #Musketeer. #amyloidosis and #echo. Tweets limited to medicine and #Xavier basketball. My own and not my employer's.
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is…
Dr. Suzanne Lentzsch, MD, PhD. Director of the Multiple Myeloma and Amyloidosis Service at Columbia University Medical Center.
Nephros is a commercial stage medical device company that develops and sells high-performance liquid purification filters. Nephros filters capture contaminants as…
Stanford IM residency program director, Cardiologist, Specialist in Amyloidosis, Cardio-Oncology, and Advanced heart failure.
BSIM's mission is to deliver quality drug candidates with high capital efficiency against transthyretin-mediated amyloidosis, including clinical manifestations and…
Twitter Handle: Director, Cardiac Amyloidosis Program, Brigham and Women's Hospital and Harvard Medical School.